ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityActive in the last 2 years
Yangyang Yue
Matched on ORCID iD 0000-0003-4281-5534; OpenAlex author ID A5045382593. Sources: OpenAlex.
Their work
- Papers
- 9
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2020: 3 papers · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 9
- MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. Co-author DOI 10.1016/j.canlet.2026.218362↗
- Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing S… Co-author DOI 10.1016/j.canlet.2023.216602↗
- Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing … Co-author DOI 10.1016/j.canlet.2022.215913↗
- Piezo1 act as a potential oncogene in pancreatic cancer progression. Co-author DOI 10.1016/j.lfs.2022.121035↗
- RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/ijbs.72204↗
- The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. Co-author DOI 10.1186/s13046-020-01823-4↗
- Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation. Co-author DOI 10.1016/j.biopha.2020.110116↗
- Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. Co-author DOI 10.1016/j.biopha.2020.110126↗
- 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling. Co-author DOI 10.1016/j.canlet.2019.11.041↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weikun Qian · 9 shared papers, 2020–2026 · strength 1.36
- Paper MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. DOI 10.1016/j.canlet.2026.218362↗
- Paper Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensiti… DOI 10.1016/j.canlet.2023.216602↗
- Paper Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensit… DOI 10.1016/j.canlet.2022.215913↗
- Qingyong Ma · 8 shared papers, 2020–2024 · strength 1.11
- Paper Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensiti… DOI 10.1016/j.canlet.2023.216602↗
- Paper Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensit… DOI 10.1016/j.canlet.2022.215913↗
- Paper RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcino… DOI 10.7150/ijbs.72204↗
- Zheng Wang · 5 shared papers, 2020–2026 · strength 0.87
- Paper MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. DOI 10.1016/j.canlet.2026.218362↗
- Paper Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensiti… DOI 10.1016/j.canlet.2023.216602↗
- Paper Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensit… DOI 10.1016/j.canlet.2022.215913↗
- Jie Li · 4 shared papers, 2020–2024 · strength 0.61
- Paper Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensiti… DOI 10.1016/j.canlet.2023.216602↗
- Paper Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensit… DOI 10.1016/j.canlet.2022.215913↗
- Paper The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. DOI 10.1186/s13046-020-01823-4↗
- Zeen Zhu · 3 shared papers, 2022–2026 · strength 0.52
- Paper MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. DOI 10.1016/j.canlet.2026.218362↗
- Paper RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcino… DOI 10.7150/ijbs.72204↗
- Paper Piezo1 act as a potential oncogene in pancreatic cancer progression. DOI 10.1016/j.lfs.2022.121035↗
- Shiqi Wu · 3 shared papers, 2020–2024 · strength 0.51
- Paper Corrigendum to "2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensiti… DOI 10.1016/j.canlet.2023.216602↗
- Paper Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensit… DOI 10.1016/j.canlet.2022.215913↗
- Paper 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inh… DOI 10.1016/j.canlet.2019.11.041↗
- Zheng Wu · 4 shared papers, 2020–2022 · strength 0.50
- Paper RASAL2 mediated the enhancement of YAP1/TIAM1 signaling promotes malignant phenotypes of pancreatic ductal adenocarcino… DOI 10.7150/ijbs.72204↗
- Paper Piezo1 act as a potential oncogene in pancreatic cancer progression. DOI 10.1016/j.lfs.2022.121035↗
- Paper 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inh… DOI 10.1016/j.canlet.2019.11.041↗
- Tao Qin · 3 shared papers, 2020–2026 · strength 0.48
- Paper MUC15 loss promotes perineural invasion in pancreatic cancer by activating the IGF1R/STAT3/NGF pathway. DOI 10.1016/j.canlet.2026.218362↗
- Paper Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. DOI 10.1016/j.biopha.2020.110126↗
- Paper The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. DOI 10.1186/s13046-020-01823-4↗
- Cancan Zhou · 4 shared papers, 2020–2022 · strength 0.46
- Paper Piezo1 act as a potential oncogene in pancreatic cancer progression. DOI 10.1016/j.lfs.2022.121035↗
- Paper Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. DOI 10.1016/j.biopha.2020.110126↗
- Paper The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. DOI 10.1186/s13046-020-01823-4↗
- Simei Zhang · 2 shared papers, 2022–2026 · strength 0.39
- Wunai Zhang · 2 shared papers, 2022–2026 · strength 0.39
- Wanxing Duan · 3 shared papers, 2020–2022 · strength 0.34
- Paper Piezo1 act as a potential oncogene in pancreatic cancer progression. DOI 10.1016/j.lfs.2022.121035↗
- Paper The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. DOI 10.1186/s13046-020-01823-4↗
- Paper Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation. DOI 10.1016/j.biopha.2020.110116↗
- Ying Xiao · 3 shared papers, 2020–2021 · strength 0.33
- Paper Huaier extract restrains pancreatic cancer by suppressing Wnt/β-catenin pathway. DOI 10.1016/j.biopha.2020.110126↗
- Paper The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. DOI 10.1186/s13046-020-01823-4↗
- Paper Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation. DOI 10.1016/j.biopha.2020.110116↗
- Li Li · 2 shared papers, 2022 · strength 0.27
- Yiqun Song · 1 shared paper, 2026 · strength 0.25
- Liang Han · 2 shared papers, 2021–2022 · strength 0.24
- Jiguang Ma · 2 shared papers, 2020–2021 · strength 0.21
- Zheng Wu · 1 shared paper, 2022 · strength 0.16
- Shuai Wu · 1 shared paper, 2022 · strength 0.14
- Zheng Wang · 1 shared paper, 2022 · strength 0.14
- Weifan Zhang · 1 shared paper, 2022 · strength 0.14
- Keping Xie · 1 shared paper, 2022 · strength 0.14
- Wei Li · 1 shared paper, 2022 · strength 0.13
- Wang Zheng · 1 shared paper, 2022 · strength 0.13
- Xuqi Li · 1 shared paper, 2020 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.